Back

FYCO1 ameliorates adverse cardiac remodeling in response to myocardial ischemia by enhancing autophagic flux

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Myocardial ischaemia and protective mechanisms Ischaemia, Infarction, Cardioprotection ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Miss Frauke Senger

University Hospital Heidelberg, Heidelberg (Germany)

4 More presentations in this session

Presentation thumbnail
Impaired Cardioprotection by HDL in CAD and Diabetes in Ischemia/Reperfusion Injury: role of S1P and SR-BI
Doctor A. Polzin (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Systemic GDF11 replenishment ignites myocardial injury through diminishing anti-apoptotic activity of cardiac progenitor cells
Doctor S. Kraler (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Cardioprotection by selective SGLT2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?
Doctor P. Nikolaou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Erythrocytes from patients with ST-elevation myocardial infarction induce cardioprotection via the purinergic P2Y13 receptor and nitric oxide signalling
Doctor T. JIAO (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial ischaemia and protective mechanisms

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
The epi-drug RVX-208 restores autophagy in cardiometabolic heart failure with preserved ejection fraction
thumbnail
Congress Presentation
The transcription factor foxo3 regulates cardiac remodeling after myocardial infarction
thumbnail
Congress Presentation
Cardiomyocyte-specific beta3-adrenergic receptor expression reduces infarct size inhibiting the autophagic flux in mice.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources